Astro-Med Reports Fourth Quarter and Fiscal 2005 Results; Directors Declare Regular Cash Dividend.

WEST WARWICK, R.I. -- Astro-Med, Inc. (NASDAQ:ALOT) reports net income of $456,000, equal to 8 cents per diluted share, on record sales of $14,496,000 for the Fourth Quarter ending January 31, 2005. During the corresponding period of the previous year, the Company reported net income of $1,000,000, equal to 17 cents per diluted share, on sales of $14,157,000.

For the twelve month period ended January 31, 2005, net income was $2,710,000, equal to 47 cents per diluted share, on sales of $55,975,000. For the corresponding period last year the Company reported net income of $3,217,000, equal to 60 cents per diluted share, on sales of $55,781,000.

Commenting on the results, Albert W. Ondis, Chief Executive Officer, stated: "We are pleased that the Company achieved record sales in the Fourth Quarter. We experienced healthy demand from our QuickLabel Systems(R) product group, where sales increased 5% over the Third Quarter and 12% for the year, as well as our Grass-Telefactor(R) product group, which grew 14% over the Third Quarter sales. Our Test & Measurement product group sales grew 15% over the Third Quarter figures. Although T&M sales declined from the prior year, this product group is benefiting from growing industry acceptance of its ruggedized airborne products including Cockpit Printers and Ethernet Switches.

"During the year we fulfilled our plan to increase revenue by expanding our overall selling and marketing activities. We hired additional field sales personnel, increased our trade shows representation and broadened our global dealer organization. Additionally, we strengthened the technical capabilities in our R&D team by adding software and electrical engineering personnel. There is great promise in the suite of new products currently under development for all three product groups.

"At the end of the year our balance sheet is even stronger with an increase in cash and marketable securities, improved current ratio and no long or short term debt. We expect continuous improvement in the year ahead as we drive the Company's strategy of sales growth and profitability."

On March 8, 2005, the Directors of Astro-Med declared the regular quarterly cash dividend of 4 cents per share payable on April 1, 2005 to shareholders of record on March 25, 2005.

The Fourth Quarter and Fiscal Year conference call will be held today, March 22, 2005, at 5:00 PM EST. It will be broadcast in real time on the Internet through our website at www.astro-med.com. We invite you to log on and listen in or access the broadcast any time for up to 5 days following the event.

Astro-Med, Inc. is a leading manufacturer of high tech specialty printing systems, electronic medical instrumentation, and test and measurement instruments employed around the world in a wide range of industrial, scientific, and medical applications.

ASTRO-MED, INC.
                 Consolidated Statement of Operations
                In Thousands Except for Per Share Data
                              (Unaudited)

                         Three-Months Ending    Twelve-Months Ending
                       January 31, January 31, January 31, January 31,
                           2005        2004        2005        2004
                       ----------- ----------- ----------- -----------
Net Sales                 $14,496     $14,157     $55,975     $55,781

Gross Profit                6,180       6,197      23,046      22,989
                             42.6%       43.8%       41.2%       41.2%
Operating Expenses:
   Selling, General &
    Administrative          4,416       4,136      16,429      15,673
   Research &
    Development             1,054         954       4,047       3,686
   Restructuring and
    Impairment                 --         (15)         --         (15)
                       ----------- ----------- ----------- -----------
                            5,470       5,075      20,476      19,344

Operating Income              710       1,122       2,570       3,645
                              4.9%        7.9%        4.6%        6.5%

Other, Net                      2          54         198         139
                       ----------- ----------- ----------- -----------

Income Before Taxes           712       1,176       2,768       3,784

Income Tax Benefit
 (Provision)                 (256)       (176)        (58)       (567)
                       ----------- ----------- ----------- -----------

Net Income                   $456      $1,000      $2,710      $3,217
                       =========== =========== =========== ===========

Net Income Per Share -
 Basic                      $0.09       $0.19       $0.51       $0.67
                       =========== =========== =========== ===========
Net Income Per Share -
 Diluted                    $0.08       $0.17       $0.47       $0.60
                       =========== =========== =========== ===========

Weighted Average Number
 of Common Shares  -
 Basic                      5,296       5,154       5,290       4,837
Weighted Average Number
 of Common Shares  -
 Diluted                    5,687       5,971       5,781       5,342

Dividends Declared Per
 Common Share               $0.04       $0.04       $0.16       $0.16


                      Selected Balance Sheet Data
                In Thousands Except for Per Share Data

                               As of            As of
                          January 31, 2005 January 31, 2004
                          ---------------- ----------------
Cash & Marketable
 Securities                       $13,983          $12,677

Current Assets                    $36,842          $32,017

Total Assets                      $47,155          $42,065

Current Liabilities                $7,574           $7,518

Shareholders' Equity              $38,408          $34,547

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2004 annual report and its annual and quarterly filings with the Securities and Exchange Commission.